Since CD4+CD28null T cells produce IFN-γ but not IL-17 [6,30], it is possible that CD4+CD28null T cells, if activated in the joint by secretion of IFN-γ, might even inhibit the synovial inflammation in RA. The gene discussed is IFNG; the disease is rheumatoid arthritis.